abstract this study investigated the effect of level of Spirulina supplementation on the fatty acid (fa) compositions of subcutaneous adipose, longissimus dorsi muscle, kidney, heart, and liver tissues in purebred and crossbred australian merino sheep. forty-eight lambs sired by black suffolk, White suffolk, dorset and merino rams were assigned into 4 treatment groups of daily Spirulina supplementation levels per lamb of 0 ml (control), 50 ml (low), 100 ml (medium) and 200 ml (high) referred to as 0, 5, 10 and 20% groups. the lambs were slaughtered after 9 weeks of supplementation and heart, kidney, adipose, liver and muscle tissue samples were collected. the results demonstrated significant variations in growth and body conformation traits and tissue and organ FA composition in response to the Spirulina supplementation. the medium-level Spirulina treatment group increased the ω-3 and ω-6 polyunsaturated fatty acid (pufa) composition in all tissues and organs significantly. The results suggest the use of medium level (100 mL/head/day) of Spirulina supplementation in order to increase lamb production with more ω-3 and ω-6 pufa and therefore higher nutritional meat quality.
Spirulina platensis is a cyanobacterium (blue-green alga) commercially produced as a nutritional supplement for humans and as a feed ingredient for livestock (Holman and Malau-Aduli, 2013) . Spirulina is produced mainly from two species of cyanobacteria: Arthrospira platensis and Arthrospira maxima. Spirulina platensis is regarded as a desirable supplement because it contains 60-70% protein and is a good source of essential vitamins and minerals (Holman and Malau-Aduli, 2013 ). In the dual-purpose prime lamb industry, accomplishing a higher quality of lamb product is central to economic success. When it comes to making purchasing decisions, carcass characteristics and meat quality are significant standards for the industry and consumers (Alfaia et al., 2009; Kouba and Mourot, 2011; Smet et al., 2004) . In red meat, the fatty acid composition and cholesterol levels have received considerable attention due to their significance in human health and product quality (Mapiye et al., 2011; Woods and Fearon, 2009) .
There are two types of factors that influence both type and composition of lipids in animal products: extrinsic and intrinsic factors such as age, genotype, gender, feeding and temperature. In recent years, there has been increased research interest in manipulating the fatty acid composition of meat. Nowadays consumers prefer healthy, naturally produced products, which has generated a lot of research interest to produce foods of higher nutritional quality, including meats (Mapiye et al., 2011; Moibi and Christopherson, 2001; Woods and Fearon, 2009 ). Modification of animal diets using bioactive feed supplements such as Spirulina is one strategy for producing such foods (Doreau et al., 2010; Iwata et al., 1990) .
Although Spirulina is the subject of recent research investigations in sheep (Kashani et al., 2015; Holman et al., 2014 Holman et al., a, 2014 Holman et al., b, 2014 Holman and Malau--Aduli, 2014; Holman and Malau-Aduli, 2013; Holman et al., 2012) , none of these papers has dealt specifically with fatty acid composition. Therefore, the major objective of this study was to investigate the effect of the level of Spirulina supplementation on the fatty acid (FA) composition of subcutaneous adipose, longissimus dorsi muscle, heart, kidney and liver tissues in dual-purpose Australian lambs. It was hypothesized that Spirulina would affect lamb tissues and organ FA composition.
material and methods
This study was carried out at the University of Tasmania (UTAS) Farm, Cambridge, Tasmania, Australia. All experimental processes conformed to the UTAS Animal Ethics Committee guidelines, the 1993 Tasmania Animal Welfare Act, and the 2004 Australian Code of Practice for the Care and Use of Animals for Scientific Purposes.
animal management, slaughter, and sampling At the UTAS Farm, Merino, Dorset, Black Suffolk, and White Suffolk terminal sires were mated over two consecutive years with purebred Merino ewes using a 1:100 ram-to-ewe mating ratio. All first progeny were identified using National Livestock Identification ear tags at birth and were weaned onto ryegrass pastures at three months of age. At 6 months of age average weaning weight of 30 kg, 48 lambs were allocated into a feeding trial using ryegrass pasture. Each treatment group had twelve lambs balanced by sire breed (Black Suffolk, White Suffolk, Dorset, and Merinos), sex (ewe, wether), and Spirulina supplementation level (Controlunsupplemented, Low, Medium and High) .
Spirulina powder was purchased (TAAU, Darwin, Northern Territory, Australia) and made into a water suspension using a 1:10 weight/volume ratio of Spirulina (g) to water (ml). The control treatment was drenched with water only without any Spirulina (0% wt:vol), Low level of supplementation was 50 mL/head/day of 1 g Spirulina powder dissolved in 10 mL of water (5% wt:vol), Medium (100 mL/head/day of 1 g Spirulina powder dissolved in 10 mL of water (10% wt:vol) and High (200 mL/head/day of 2 g of Spirulina dissolved in 10 mL of water (20% wt:vol). Each lamb was directly provided with its assigned Spirulina supplementation level daily via oral drenching. At weekly intervals, each lamb was individually assessed for chest girth (CG), withers height (WH), body length (BL), body condition score (BCS) and liveweight (BWT) measurements. CG was the body circumference measured at just behind the forelegs (Afolayan et al., 2006) . WH was the distance between the highest peak over the scapulae and the ground (Sowande and Sobola, 2008) . BL refers to the span between the base of the neck, the vertebrae between the scapulae, to the far point of the pubic bone (Sowande and Sobola, 2008) . BCS was subjectively measured (Phythian et al., 2012) , always by the same researcher, gauging fat depth on a 0-5 point scale as described by McLeod et al. (2010) . BWT was monitored using an electronic walk-over weighing scale equipped with an automatic sheep ID scanning digitally downloadable data capability. Body conformation measurements in centimetres were taken using the same measuring tape. During assessment it was ensured that lambs were gently restrained in a relaxed state on all four legs with their heads comfortably erect. All experimental lambs were slaughtered at the completion of the feeding trial (finishing weight ranging from 40 to 45 kg) at a commercial abattoir (Gretna Quality Meats, Gretna, Tasmania, Australia). Subcutaneous adipose fat, kidney, liver, heart, and longissimus dorsi muscle tissue samples were immediately removed from each carcass and frozen in liquid nitrogen, transported to the laboratory, and stored at -20°C for further analysis.
lipid extraction and Gc analysis
All tissue samples (subcutaneous adipose, kidney, heart, liver, and muscle) were extracted using a modified Bligh and Dyer protocol (Bligh and Dyer, 1959) . This involved a single-phase overnight extraction using CHCl 3 :MeOH:H 2 O (1:2:0.8 v/v), followed by phase separation with the addition of CHCl 3 :saline H 2 O (1:1 v/v). The total lipid extract was obtained by rotary evaporation of the lower chloroform phase.
An aliquot of total lipid extracted from each sample was transmethylated in MeOH:CHCl 3 :HCl (10:1:1 v/v) for 2 h at 80°C. Milli-Q H 2 O (1 ml) was then added before FA methyl esters (FAME) were extracted with hexane:chloroform (4:1 v/v) and reduced under a nitrogen stream, and a known concentration of an internal injection standard (19:0 FAME) was added. An Agilent Technologies 7890B gas chromatograph (GC) (Palo Alto, California, USA) equipped with an Equity™-1 fused silica capillary column (15 m × 0.1 mm internal diameter and 0.1-µm film thickness), a flame ionisation detector, a split/splitless injector, and an Agilent Technologies 7683 B Series autosampler was used in the analysis.
Samples were injected in splitless mode and carried by helium gas at an oven temperature of 120°C. Post injection, the oven temperature was increased to 270°C at 10°C/min, and then to 310°C at 5°C/min. Peaks were quantified by Agilent Technologies ChemStation software (Palo Alto, California, USA). FA identities were confirmed using GC-mass spectrometric (GC/MS) analysis. These analyses were performed using a Finnigan Thermoquest GCQ GC-MS fitted with an on-column injector with Thermoquest Xcalibur software (Austin, Texas, USA). The GC had an HP-5 cross-linked methyl silicone-fused silica capillary column (50 m × 0.32 mm internal diameter). The carrier gas used was helium, with operating conditions previously described (Miller et al., 2006) .
statistical analysis
Individual FAs and the summations of saturated, monounsaturated, and polyunsaturated FAs were computed as percentages of total FAs. Statistical Analysis System software (SAS, 2009) was used to analyse the data, and summary statistics were computed with means, standard deviations, and minimum and maximum values to check for errors and outliers. Repeated measures analysis of variance in general linear models procedure (PROC GLM), using Statistical Analysis System (SAS, 2009) was then carried out by fitting the level of Spirulina supplementation, sire breed, sex and tissue as fixed effects in the model and using FA values as dependent variables (14:0, 15:0, 16:1ω9c, 16:1ω7c, 16:0, 17:0, 18:2ω6, 18:3ω3, 18:1ω9, 18:1ω7c, 18:1ω7t, 18:0, 20:4ω6, 20:5ω3, 20:3ω6, 20:4ω3, 20:2ω6, 20:0, 22:5ω6, 22:6ω3, 22:5ω3, 22:0, 23:0, 24 :0, ∑SFA, ∑MUFA, ∑PUFA, ∑ω-3 PUFA, ∑ω-6 PUFA). Bonferroni's probability pairwise comparison test was used to separate mean differences, with the level of significance defined as P<0.05.
results

Spirulina supplementation and phenotypic data
Spirulina supplementation enabled sheep to grow longer bodies (BL) than the control group (P<0.015). Furthermore, lambs in the high (20%) Spirulina supplementation treatment group had a greater body condition score (BCS) than the medium (10%), low (5%), and control (0%) treatments (P<0.001). It was observed that the sheep receiving medium Spirulina supplementation had the greatest body weight (BWT) of 41.9 kg (P<0.018), but no differences between the high, low, and control treatment groups were observed. The phenotypic results are shown in Table 2 .
Spirulina and tissue fatty acids
The fatty acid composition of Spirulina analysed by GC-MS is listed in Table 1 . The Spirulina diet had a significant effect on subcutaneous adipose, longissimus dorsi muscle, heart, kidney, and liver tissue FA compositions of 14:0, 15:0, 16:1ω7c, 16:0, 17:0, 18:2ω6, 18:1ω9, 18:1ω7c, 20:5ω3, 20:3ω6, 20:4ω3, 20:2ω6, 20:0, 22:5ω6, 22:6ω3, ∑SFA, . In addition, the Spirulina diet significantly affected the profile of 16:0, 18:1ω9, 20:5ω3, and 22:5ω6 in two or more tissues (Table 3). Column means within a fixed effect bearing different letters significantly differ (P<0.05). Chest girth (CG), withers height (WH), body length (BL), body condition score (BCS), body weight (BWT), and average daily weight gain (ADG). Level of significance: * significant (P<0.05), ** highly significant (P<0.01), and *** very highly significant (P<0.001).
tissue fatty acid content Adipose: In the subcutaneous adipose tissue, the level of 16:1ω7c composition was found to be higher by 1.2% in the tissues of animals that received medium and high levels of Spirulina compared to the control (0.9%) and low (1.1%) levels of supplementation (Table 4 ). The highest composition of 18:2ω6 (linoleic acid) was discovered in the tissues associated with the medium level of Spirulina supplementation (1.8%) with a significant difference (P<0.05), in contrast to the compositions for the other supplementation levels, which did not differ significantly (Table 4) . 15:1ω6, 16:1ω9, 16:1ω7, Br17:1, 17:1ω8+a17:0, 17:1, 18:1ω9, 18:1ω7, 18:1ω5, 18:1, 19:1, 20:1ω11, 20:1ω9, 20:1ω7, 20:1ω5, 22:1ω9, 22:1ω11, 22:1ω7, 24:1ω11, 24:1ω9, 24:1ω7 ; ∑PUFA is the sum of 16: 3+16:4, 16:2, 18:4ω3, 18:3ω6, 18:2ω6, 18:3ω3, 20:4ω3, 20:4ω6, 20:5ω3, 20:3ω6, 20:2ω6, 21:5ω3, 22:6ω3, 22:5ω3, 22:5ω6, 22:4ω6, 24:6ω3, 24:5ω3;∑ω-3 PUFA is the sum of 18:3ω3, 18:4ω3, 20:4ω3, 20:5ω3, 21:5ω3, 22:6ω3, 22:5ω3, 24:6ω3, 24:5ω3; ∑ω-6 PUFA is the sum of 18:2ω6, 18:3ω6, 20:4ω6, 20:3ω6, 20:2ω6, 22:5ω6, 22:4ω6 . Level of significance: * significant (P<0.05), ** highly significant (P<0.01), and *** very highly significant (P<0.001).
For 20:5ω3 (eicosapentaenoic acid), the highest composition of 0.2 (Table 4) was observed for the medium supplementation levels, which significantly differed (P<0.05) from the low and control supplementation levels. However, no significant difference was found compared to the high supplementation level (Table 4 ). In the adipose tissue, the highest level of 20:0 composition (arachidic acid) was 0.2% (Table 4), which was found in tissues associated with low level of supplementation with a significant difference (P<0.01). This was followed by 0.1% for the control and high supplementation levels (Table 4 ). The lowest level of arachidic acid in adipose tissues was recorded for the medium level of supplementation. The medium level of supplementation produced the highest ∑ω-6 composition of 2.1 (Table 4) , which significantly differed from other tissues. The ∑ω-6 composition was observed to be significantly higher for both low and high supplementations compared to the control group (Table 4) . 15:1ω6, 16:1ω9, 16:1ω7, Br17:1, 17:1ω8+a17:0, 17:1, 18:1ω9, 18:1ω7, 18:1ω5, 18:1, 19:1, 20:1ω11, 20:1ω9, 20:1ω7, 20:1ω5, 22:1ω9, 22:1ω11, 22:1ω7, 24:1ω11, 24:1ω9, 24:1ω7 ; ∑PUFA is the sum of 16: 3+16:4, 16:2, 18:4ω3, 18:3ω6, 18:2ω6, 18:3ω3, 20:4ω3, 20:4ω6, 20:5ω3, 20:3ω6, 20:2ω6, 21:5ω3, 22:6ω3, 22:5ω3, 22:5ω6, 22:4ω6, 24:6ω3, 24:5ω3;∑ω-3 PUFA is the sum of 18:3ω3, 18:4ω3, 20:4ω3, 20:5ω3, 21:5ω3, 22:6ω3, 22:5ω3, 24:6ω3, 24:5ω3; ∑ω-6 PUFA is the sum of 18:2ω6, 18:3ω6, 20:4ω6, 20:3ω6, 20:2ω6, 22:5ω6, 22:4ω6. c FA not found (%total FA = 0) were 20:3ω6, 20:4ω3, 22:5ω3, 22:0, 23:0, 24:0.
Longissimus dorsi muscle:
The level of palmitic acid (16:0) in the muscle tissue of control group was higher than that for the low, medium, and high levels of supplementation with a significant difference (P<0.05) ( Table 5 ). For 17:0 (heptadecanoic acid) muscle composition, the low level of supplementation differed significantly (P<0.01) from other supplementation levels, having the highest composition of 1.6% (Table 5 ). Both the low and high levels of supplementation had the highest 18:1ω7c muscle composition (1.5%), which significantly differed (P<0.05) from the control and medium levels (Table 5 ). For 20:5ω3 (eicosapentaenoic acid), the highest muscle composition of 0.5% was found with the medium and high supplementation levels, which significantly differed (P<0.05) from the control and low-level supplementation groups (Table 5 ). , 19:1, 20:1ω11, 20:1ω9, 20:1ω7, 20:1ω5, 22:1ω9, 22:1ω11, 22:1ω7, 24:1ω11, 24:1ω9, 24:1ω7 ; ∑PUFA is the sum of 16: 3+16:4, 16:2, 18:4ω3, 18:3ω6, 18:2ω6, 18:3ω3, 20:4ω3, 20:4ω6, 20:5ω3, 20:3ω6, 20:2ω6, 21:5ω3, 22:6ω3, 22:5ω3, 22:5ω6, 22:4ω6, 24:6ω3, 24:5ω3;∑ω-3 PUFA is the sum of 18:3ω3, 18:4ω3, 20:4ω3, 20:5ω3, 21:5ω3, 22:6ω3, 22:5ω3, 24:6ω3, 24:5ω3; ∑ω-6 PUFA is the sum of 18:2ω6, 18:3ω6, 20:4ω6, 20:3ω6, 20:2ω6, 22:5ω6, 22:4ω6. Heart: The lowest 15:0 (pentadecanoic acid) fatty acid composition in heart tissue of 0.2% was discovered in tissues supplemented with low levels, while the compositions for other supplementations did not differ significantly (Table 6 ). The 16:0 (palmitic acid) fatty acid composition differed (P<0.05) in heart tissues supplemented with low and medium levels compared to the control (Table 6 ). The medium level of supplementation was associated with the lowest 16:0 composition of 14.1%, followed by the low level (14.7%) ( Table 6 ). Tissues supplemented with medium levels had the highest 20:2ω6 (eicosadienoic acid) composition of 0.1%, which differed significantly (P<0.01), whereas other supplementation compositions did not differ significantly (Table 6 ). The 18:1ω9 (oleic acid) heart composition was discovered to be higher for both the low and medium supplementation levels (Table 6). The 20:4ω3 (eicosatetraenoic acid) composition in heart tissue was found to be highest at 0.1% and significantly differed from the control, low, and medium levels of supplementations (Table 6 ). 15:1ω6, 16:1ω9, 16:1ω7, Br17:1, 17:1ω8+a17:0, 17:1, 18:1ω9, 18:1ω7, 18:1ω5, 18:1, 19:1, 20:1ω11, 20:1ω9, 20:1ω7, 20:1ω5, 22:1ω9, 22:1ω11, 22:1ω7, 24:1ω11, 24:1ω9, 24:1ω7 ; ∑PUFA is the sum of 16: 3+16:4, 16:2, 18:4ω3, 18:3ω6, 18:2ω6, 18:3ω3, 20:4ω3, 20:4ω6, 20:5ω3, 20:3ω6, 20:2ω6, 21:5ω3, 22:6ω3, 22:5ω3, 22:5ω6, 22:4ω6, 24:6ω3, 24:5ω3;∑ω-3 PUFA is the sum of 18:3ω3, 18:4ω3, 20:4ω3, 20:5ω3, 21:5ω3, 22:6ω3, 22:5ω3, 24:6ω3, 24:5ω3; ∑ω-6 PUFA is the sum of 18:2ω6, 18:3ω6, 20:4ω6, 20:3ω6, 20:2ω6, 22:5ω6, 22:4ω6. 15:1ω6, 16:1ω9, 16:1ω7, Br17:1, 17:1ω8+a17:0, 17:1, 18:1ω9, 18:1ω7, 18:1ω5, 18:1, 19:1, 20:1ω11, 20:1ω9, 20:1ω7, 20:1ω5, 22:1ω9, 22:1ω11, 22:1ω7, 24:1ω11, 24:1ω9, 24:1ω7 ; ∑PUFA is the sum of 16: 3+16:4, 16:2, 18:4ω3, 18:3ω6, 18:2ω6, 18:3ω3, 20:4ω3, 20:4ω6, 20:5ω3, 20:3ω6, 20:2ω6, 21:5ω3, 22:6ω3, 22:5ω3, 22:5ω6, 22:4ω6, 24:6ω3, 24:5ω3;∑ω-3 PUFA is the sum of 18:3ω3, 18:4ω3, 20:4ω3, 20:5ω3, 21:5ω3, 22:6ω3, 22:5ω3, 24:6ω3, 24:5ω3; ∑ω-6 PUFA is the sum of 18:2ω6, 18:3ω6, 20:4ω6, 20:3ω6, 20:2ω6, 22:5ω6, 22:4ω6. c FA not found (%total FA = 0) were 20:4ω3, 20:2ω6.
Kidney:
The 18:1ω9 (oleic acid) composition of the kidney was higher for the lowsupplementation group compared to the control, medium, and high-supplementation groups (P<0.05) ( Table 7 ). The 22:5ω6 (docosapentaenoic acid) composition of the kidney for the medium and high supplementation was highest at 0.9% and 0.5%, respectively, which significantly differed (P<0.05), whereas the other compositions did not (Table 7 ). The 22:6ω3 (docosahexaenoic acid) composition of the kidney for the high supplementation was the highest at 3.4% with a significant difference (P<0.05) from the control, low, and medium supplementation levels ( Table 7) . The ∑PUFA kidney composition of the medium and high supplementation levels was higher compared to the control and low levels of supplementation (P<0.05) (Table 7).
Liver: The liver from the control and low-supplementation groups had the highest 14:0 (myristic acid) compositions of 0.6% and 0.5%, respectively, with significance (P<0.01), followed by the lowest observed 14:0 composition of 0.3% in the medium and high-supplementation groups (Table 8 ). The 20:5ω3 (eicosapentaenoic acid) composition of the liver from the low, medium, and high-supplementation groups were significantly higher (P<0.05) than the control supplement level of 1.0% (Table 8 ). For 20:3ω6 (dihomo-γ-linolenic acid) in the liver, the highest compositions were found for both the medium and high supplementation levels at 0.6% and 0.5%, respectively (Table 8 ). The composition of 22:5ω6 (docosapentaenoic acid) in the liver was the highest at 1.1% for the medium-supplementation group, which significantly differed from the other supplementation levels (P<0.05) ( Table 8) .
discussion
Spirulina has been the subject of recent studies in sheep (Kashani et al., 2015; Holman et al., 2014 Holman et al., a, 2014 Holman et al., b, 2014 Holman and Malau-Aduli, 2014; Holman and Malau-Aduli, 2013; Holman et al., 2012) , but there is still a knowledge gap with regard to its impact on FA composition. In this study, FA data were converted into percentages of total FA composition (as % total FA). Aspects of the FA profile were evaluated to provide deeper insight into the effect of Spirulina supplementation on FA composition in Australian dual-purpose lambs. It was demonstrated that the medium-level Spirulina diet resulted in higher polyunsaturated fatty acid (PUFA) compositions.
Studies have demonstrated that diets with high FA content have a major impact on the fatty acid composition of ruminants (Alfaia et al., 2009; Raes et al., 2004; Wachira et al., 2007) . Research has shown that ruminant PUFA including ω-3 and ω-6 content, can be improved by increased dietary intake of α-linolenic acid (ALA) and linoleic acid (LA) (Wachira et al., 2007; Wood and Enser, 1997; Wood et al., 2004) . ALA is an important ω-3 fatty acid that is used as a precursor for the production of long chain ω-3 fatty acids including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (Abeywardena and Patten, 2011; Belay et al., 1993; Daley et al., 2010; Kouba and Mourot, 2011; Raes et al., 2004) . Similarly, LA is the most prevalent ω-6 fatty acid that is converted to its longer chain counterpart arachidonic acid (ARA) through a series of conversions (Doreau et al., 2010; Price et al., 2000; Woods and Fearon, 2009 ).
The Spirulina diet was rich in the essential fatty acids ALA, LA, and DGLA (Iwata et al., 1990; Qureshi et al., 1996; Ross and Dominy, 1990) . Thus, it is acceptable to presume that these dietary ingredients contributed to the observed levels of individual and total tissue ω-3 and ω-6 PUFAs (Fokkema et al., 2002; Pethick et al., 2010) . In our study, the medium-level Spirulina diet increased EPA and LA significantly in subcutaneous adipose tissue, which increased the percentage of Σω-6 PUFA. Research has demonstrated that EPA is an essential and physiologically significant ω-3 fatty acid (Abeywardena and Patten, 2011; Belay et al., 1993; Daley et al., 2010; Mapiye et al., 2011; Woods and Fearon, 2009) because it is an essential ω-3 fatty acid that is needed by the human body, which cannot synthesise EPA and must thus acquire it from food or supplement sources.
It was discovered that the medium Spirulina diet increased EPA in subcutaneous adipose, muscle, and liver tissues. The low Spirulina diet reduced the percentage of pentadecanoic acid in the heart tissue (Hoashi et al., 2008; Scollan et al., 2001) compared to the adipose tissue. This is because the Spirulina supplement is rich in α-linolenic acid. Pentadecanoic acid is a saturated FA found in milk fat from cows (Cooper et al., 2004; DeBusk, 2010) , and it is also detected in hydrogenated mutton fat (Scollan et al., 2001; Woods and Fearon, 2009 ). This finding suggests that the low-level Spirulina diet reduces the conversion of unsaturated fatty acids to saturated fatty acids thus supporting the theory of reduced biohydrogenation (Kouba and Mourot, 2011; Pethick et al., 2010) in crossbred lambs. An increase in eicosadienoic acid (20:2ω-6) was observed in the tissues associated with the low-level Spirulina diet.
Eicosadienoic acid (EDA) is a naturally occurring ω-6 PUFA found mainly in animal tissues (Daley et al., 2010) . EDA is elongated from linoleic acid (LA) (Kouba and Mourot, 2011; Price et al., 2000) and can be further metabolised to dihomo-γ--linolenic acid (DGLA) and arachidonic acid (AA) (Daley et al., 2010; Mapiye et al., 2011; Price et al., 2000) . This indicates that an LA-rich diet can increase EDA elongation, which is then further metabolized to arachidonic acid (Mapiye et al., 2011; Moibi and Christopherson, 2001; Nguyen et al., 2010) . The role of arachidonic acid includes keeping cell membranes flexible and permeable (Pethick et al., 2010; Price et al., 2000) , and it also promotes muscle growth (Fokkema et al., 2002; Rowe, 2010; Santos-Silva et al., 2002) .
It was demonstrated that the medium Spirulina diet significantly affected the percentage of docosapentaenoic acid in kidney tissue. Docosapentaenoic acid is an ω-3 FA (Kouba and Mourot, 2011). It is formed metabolically from linolenic acid and is a constituent of animal glycerophospholipids (Scollan et al., 2001; Smet et al., 2004; Wachira et al., 2007) . This highlights that a Spirulina diet rich in LA increases other ω-6 PUFAs in Australian crossbred lambs, including long-chain ω-6.
The Spirulina diets were shown to affect the composition of oleic acid in Longissimus dorsi muscle tissue. Oleic acid is classified as a monounsaturated ω-9 FA (Daley et al., 2010, Kouba and Mourot, 2011) . Previous studies have found significant variation of FA composition in response to dietary supplementation (Alfaia et al., 2009; Doreau et al., 2010; Mapiye et al., 2011; Scollan et al., 2001) . The biosynthesis of oleic acid involves the action of the enzyme stearoyl-CoA 9-desaturase (Wood et al., 2008) acting on stearoyl-CoA (Price et al., 2000; Woods and Fearon, 2009 ) and the dehydrogenation of stearic acid to give the MUFA derivative oleic acid (Wood et al., 2008; Wood et al., 2004; Woods and Fearon, 2009) .
The Spirulina diet resulted in the reduction of palmitic acid (C16:0), which is the first fatty acid produced during fatty acid synthesis (Wood et al., 2008; Wood et al., 2004) . Palmitic acid is a precursor to longer fatty acids (Wachira et al., 2002) that is regulated by a negative feedback controlled by acetyl-CoA carboxylase (ACC) (Kouba and Mourot, 2011; Santos-Silva et al., 2002) . ACC is responsible for converting acetyl-CoA to malonyl-CoA (Smet et al., 2004; Wood and Enser, 1997) , which is used to add to the growing acyl chain, thus preventing further palmitate generation (Price et al., 2000; Raes et al., 2004; Rowe, 2010) . Research has demonstrated that palmitic acid increases the risk of developing cardiovascular diseases, thus lower levels are favourable for human health (Abeywardena and Patten, 2011; Belay et al., 1993; Fokkema et al., 2002) . In this study, the compositions of longissimus and heart muscles were favourably improved in lambs supplemented with medium levels of Spirulina as this treatment produced the lowest levels of palmitic acid and highest levels of linoleic acid and Ʃω-6 PUFA.
conclusion This study has identified the composition variation in the FA profiles of lamb adipose, muscle, heart, kidney and liver tissues attributable to differences in the level of Spirulina supplementation. The medium level of Spirulina supplementation elevated the proportions of ω-3 and ω-6 PUFA in all tissues and organs. Low and high levels of Spirulina supplementation slightly increased PUFA in some tissues and organs. Based on this study's findings, the use of 100 mL/head/day of Spirulina supplementation is optimal for enhancing PUFA levels in lamb from dual-purpose sheep production systems utilising ryegrass pastures as basal diet. acknowledgements This research was funded by grants and postgraduate scholarships from the University of Tasmania and the Australian Wool Education Trust. We thank Chris Gunn, John Otto, Will Bignell and Barrie Wells for their input during the sheep breeding and feeding trials. 
